A new study has revealed that people who suffer from gout may be less likely to develop Alzheimer's disease. The same uric acid that can crystallize to cause gout, may offer protection against Alzheimer's with its antioxidant properties.
Researchers from the United States and Canada looked at the records of 3.7 million people over the age of 40-years in a British database of medical charts. They compared data on people with gout, and those without, who developed Alzheimer's disease in a followup period of about five years.
Gout
High levels of uric acid in blood and recurring attacks of joint inflammation are the main symptoms of gout. Lifestyle changes like weight loss, increasing fluid intake and dietary changes can help.
Advertisement
Only 309 new cases of Alzheimer's among 59,224 gout sufferers with an average age of 65 were identified in the study, while there were 1,942 cases among 238,805 non-sufferers. This amounted to a 24 percent lower risk of Alzheimer's disease for people with a history of gout, after considering differences in age, gender, body weight, lifestyle and health.
The study appears online in the journal Annals of the Rheumatic Diseases.
Source: Medindia
Source: Medindia
Gout and Diet
In gout excess of uric acid appears in the blood and its particles are deposited in joints as tophi.
Advertisement
 Alzheimers DiseaseAlzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others. | Advertisement
|
Risk Factors for Alzheimers Disease
Cognitively normal adults exhibiting atrophy of their temporal lobe or damage to blood vessels in the brain are more likely to develop Alzheimer's disease.
Advertisement
Recommended Reading
Latest Research News
Injury to the white matter explains why football players are at an increased risk for cognitive and behavioral problems later in life.
Located at the South Col, the rocky area between Mount Everest and Lhotse serves as the final campsite for climbers as well as a frozen legacy of hardy microbes.
The new finding is found to be valuable for screening specific medications and treatment against Giardia and other protozoan parasites.
New CRISPR genome-editing strategy was found to have a positive impact in the treatment of inherited retinal diseases such as retinitis pigmentosa.
H3N2 Influenza: The newly developed RT-qPCR Kit to identify influenza, COVID-19 and respiratory virus has got approval from ICMR.